{"id":17989,"date":"2021-01-06T12:59:49","date_gmt":"2021-01-06T10:59:49","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=17989"},"modified":"2021-01-06T12:59:49","modified_gmt":"2021-01-06T10:59:49","slug":"nvspl-isigyja-istoriskai-didziausia-kieki-priemoniu-skirtu-covid-19-tyrimams","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2021\/01\/06\/nvspl-isigyja-istoriskai-didziausia-kieki-priemoniu-skirtu-covid-19-tyrimams\/","title":{"rendered":"NVSPL \u012fsigyja istori\u0161kai did\u017eiausi\u0105 kiek\u012f priemoni\u0173, skirt\u0173 COVID-19 tyrimams"},"content":{"rendered":"<p><strong>Nacionalin\u0117 visuomen\u0117s sveikatos prie\u017ei\u016bros laboratorija (NVSPL) \u0161iomis dienomis pasira\u0161o naujas sutartis d\u0117l COVID-19 tyrimams b\u016btin\u0173 priemoni\u0173 \u012fsigijimo dar ruden\u012f prad\u0117tuose vie\u0161uosiuose pirkimuose atviro konkurso b\u016bdu. Tai did\u017eiausios vert\u0117s centralizuotas priemoni\u0173, skirt\u0173 COVID-19 tyrimams atlikti, pirkimas Lietuvos istorijoje. Perkamas priemoni\u0173 kiekis planuotas pusme\u010diui.<\/strong><\/p>\n<p>\u201eVienas pirm\u0173j\u0173 esmini\u0173 sprendim\u0173, at\u0117jus vadovauti NVSPL, buvo vie\u0161\u0173j\u0173 pirkim\u0173 strategijos pakeitimas ir j\u0173 inicijavimas tokiu b\u016bdu, kad priemoni\u0173 vieno pirkimo metu b\u016bt\u0173 \u012fsigyjamas didesnis kiekis negu anks\u010diau. Taip ma\u017einama rizika priemon\u0117ms pasibaigti nesp\u0117jus \u012fvykti kitiems vie\u0161iesiems pirkimams, kuri\u0173 trukm\u0117 yra bent keletas m\u0117nesi\u0173. Labai d\u017eiugu pagaliau sulaukti \u0161i\u0173 vie\u0161\u0173j\u0173 pirkim\u0173 rezultat\u0173, nes, \u012fsigijus didesn\u012f kiek\u012f, atsiranda galimyb\u0117s ir rezervo k\u016brimui\u201c, \u2013 sako NVSPL vadovas Danas Bak\u0161a, \u012fstaigai vadovaujantis nuo 2020 m. spalio m\u0117nesio.<\/p>\n<p>NVSPL jau anks\u010diau yra prista\u010diusi 3 \u017eingsni\u0173 tvaraus tiekimo program\u0105, kurios viena i\u0161 dali\u0173 yra pasyviojo rezervo suk\u016brimas. Tai pad\u0117t\u0173 ateityje i\u0161vengti galim\u0173 testavimo sutrikim\u0173, toki\u0173 kaip priemoni\u0173 tiekimo sustojimas, logistikos trikd\u017eiai, priemoni\u0173 tr\u016bkumas rinkoje, staig\u016bs poreikio \u0161uoliai ir t. t.<\/p>\n<p>Sutartys d\u0117l priemoni\u0173 \u012fsigijimo sudaromos su pirmos vietos laim\u0117tojais, pasi\u016bliusiais ma\u017eiausi\u0105 kain\u0105. Pirkimus vykdo V\u0161\u012e CPO LT.<\/p>\n<p>Sutartis d\u0117l 1 mln. 830 t\u016bkst.\u00a0vnt. centrif\u016bgini\u0173 m\u0117gintuv\u0117li\u0173 \u012fsigijimo sudaroma su MB \u201eReiLaboratorium\u201c. Vieneto kaina: 0,11 EUR. Palyginimui \u2013 paskutinio atviro konkurso laim\u0117tojo vieneto kaina \u2013 0,12 EUR.<\/p>\n<p>Sutartys d\u0117l 1 mln. 830 t\u016bkst.\u00a0vnt. tampon\u0117li\u0173 \u0117mini\u0173 pa\u0117mimui i\u0161 nosiarykl\u0117s ir 1 mln. 830 t\u016bkst.\u00a0vnt. tampon\u0117li\u0173 \u0117mini\u0173 pa\u0117mimui i\u0161 gerkl\u0117s sudaromos su UAB \u201eMediq Lietuva\u201c. Vieneto kaina \u2013 0,12 EUR. Palyginimui \u2013 paskutinio atviro konkurso laim\u0117tojo vieneto kaina \u2013 0,30 EUR.<\/p>\n<p>Sutartis d\u0117l 7 t\u016bkst. 320\u00a0vnt. (po 500 ml) virusin\u0117s terp\u0117s \u012fsigijimo sudaroma su UAB \u201eNorth speed\u201c. Vieneto kaina \u2013 5,93 EUR. Palyginimui \u2013 paskutinio atviro konkurso laim\u0117tojo vieneto kaina \u2013 6,90 EUR.<\/p>\n<p>NVSPL taip pat perka\u00a01 mln. 488\u00a0t\u016bkst.\u00a0vnt. PGR reagent\u0173 ir 1 mln. 432\u00a0t\u016bkst.\u00a0vnt. RNR reagent\u0173. \u0160i\u0173 reagent\u0173 pirkimas i\u0161skaidytas \u012f skirtingas dalis d\u0117l skirting\u0173 laboratorij\u0173 \u012frangos specifikos. Sutartys jau sudarytos su UAB \u201eDiamedica\u201c d\u0117l dviej\u0173 pirkimo dali\u0173. Dalis sutar\u010di\u0173 jau i\u0161si\u0173sta tiek\u0117jams pasira\u0161ymui, o dalis pirkim\u0173 dar n\u0117ra pasibaig\u0119, sutar\u010di\u0173 sudarymo laukiama m\u0117nesio viduryje.<\/p>\n<p>Pa\u017eym\u0117tina, jog valstyb\u0117 neprival\u0117s i\u0161pirkti vis\u0173 sutartimis numatyt\u0173 kieki\u0173. Sutartyse yra numatyta galimyb\u0117 nei\u0161pirkti viso kiekio, tiek pasikeitus epidemiologinei situacijai, tiek ir d\u0117l kit\u0173 prie\u017eas\u010di\u0173.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/sam.lrv.lt\/uploads\/sam\/documents\/images\/lentele.jpg?w=1200&#038;ssl=1\" alt=\"\" \/><\/p>\n<p><em>NVSPL informacija<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nacionalin\u0117 visuomen\u0117s sveikatos prie\u017ei\u016bros laboratorija (NVSPL) \u0161iomis dienomis pasira\u0161o naujas sutartis d\u0117l COVID-19 tyrimams b\u016btin\u0173 priemoni\u0173 \u012fsigijimo dar ruden\u012f prad\u0117tuose vie\u0161uosiuose pirkimuose atviro konkurso b\u016bdu. Tai did\u017eiausios vert\u0117s centralizuotas priemoni\u0173, skirt\u0173 COVID-19 tyrimams atlikti, pirkimas Lietuvos istorijoje. Perkamas priemoni\u0173 kiekis planuotas pusme\u010diui. \u201eVienas pirm\u0173j\u0173 esmini\u0173 sprendim\u0173, at\u0117jus vadovauti NVSPL, buvo vie\u0161\u0173j\u0173 pirkim\u0173 strategijos pakeitimas ir&hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-17989","post","type-post","status-publish","format-standard","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-4G9","jetpack_featured_media_url":"","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/17989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=17989"}],"version-history":[{"count":2,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/17989\/revisions"}],"predecessor-version":[{"id":17992,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/17989\/revisions\/17992"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=17989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=17989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=17989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}